ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

NCAB Meeting Moved To October

July 20, 1979

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

Organ Systems Program Reorganization Complete; Annual Conferences To Replace Working Groups

May 26, 1989